Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole in Preterm Infants With GER
NCT01946971Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lansoprazole in gastroesophageal reflux disease (GERD), sponsored by Seoul National University Hospital. Started Sep 2013; status: completed.
02
Drugs
lansoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01946971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01946971.